Lesson plan
Ethchlorvynol
Ethchlorvynol is a GABA A receptor positive allosteric modulator with hypnotic and sedative properties, first developed by Pfizer in the 1950s. In the United States, it was sold by Abbott Laboratories under the trade name Placidyl. Placidyl was available in 200 mg, 500 mg, and 750 mg strength gel-filled capsules. The 500 mg and 750 mg capsules were intended to reduce sleep latency, while the 200 mg capsule was intended to re-induce sleep in cases of early awakening. Abbott discontinued production in 1999, largely because benzodiazepines (such as Librium and Valium) had replaced non-barbiturate sedatives in clinical practice; by the end of 2001 remaining supplies in the United States had been exhausted.
Article summary
Ethchlorvynol is a GABA A receptor positive allosteric modulator with hypnotic and sedative properties, first developed by Pfizer in the 1950s. In the United States, it was sold by Abbott Laboratories under the trade name Placidyl. Placidyl was available in 200 mg, 500 mg, and 750 mg strength gel-filled capsules. The 500 mg and 750 mg capsules were intended to reduce sleep latency, while the 200 mg capsule was intended to re-induce sleep in cases of early awakening. Abbott discontinued production in 1999, largely because benzodiazepines (such as Librium and Valium) had replaced non-barbiturate sedatives in clinical practice; by the end of 2001 remaining supplies in the United States had been exhausted.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.